THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13 ... We expect to share additional clinical data from the dose escalation of the Phase 1/2 trial of ARV-110 at the American Society of Clinical Oncology (ASCO) annual meeting in the second quarter of 2020 and from the dose ... ................
................